Relieving breathlessness in COPD
Breathlessness, the most common symptom in patients with chronic obstructive pulmonary disease (COPD), greatly reduces their ability to participate in day-to-day activities.
Therapy
Safer canes and crutches
The biomechanical features of the human ankle inspired the design of a new safety tip called Fedrofuss.
The high cost of bipolar disorder
The most expensive behavioural healthcare diagnosis, for sufferers and their insurers, is bipolar disorder, according to a study published in the American Journal of Psychiatry (160:1286-1290, July 2003).
Taxus
France - Four studies of three TAXUS paclitaxel-eluting stents have demonstrated their safety and efficacy, according to the maker, Boston Scientific Corporation of Natick, Maryland, USA.
Web advisories aid physicians
Monitoring and rapidly introducing new developments into everyday practice is an increasingly difficult task for many doctors. Additionally, patients are more informed due to media medical reports, which raise their expectations that doctors can offer a quick, reliable interpretation of the latest medical data.
Stimulating cell metabolism
G-ogo sport, a new innovation from Dr. Goettfert Systems, uses a pulsing magnetic field to stimulate cell metabolism.
CE approved
The Biotronik Home Monitoring Service, which gained CE approval in May, has now monitored over 1,500 patients worldwide. Studies indicate that 88% of patients claim an increased sense of security due to the service.
High-cal intake: Hope for bowel cancer?
France - Less than 50% of those affected by bowel cancer survive beyond five years after diagnosis. However, new research* surprisingly suggests that a high calorie diet may increase chances of survival for longer.
HIV
Medication regimes based on cocktails of antiretroviral drugs can reduce the AIDS virus to almost undetectable levels.
Hormone-resistant prostate cancer
Prostate cancer, the most common neoplasm in men, often progresses from an androgen-dependant state (and is commonly treated by androgen ablation therapies) to a hormone-refractory stage, therefore making hormone therapy ineffective. The response duration to androgen ablation therapy is finite and ultimately most prostate cancer will become hormone-insensitive.
Precision radio therapy
Professor Wolfgang Schlegel, Head of the Department of Medical Physics at the German Cancer Research Centre, has been awarded the 2003 clinical section of the German Cancer Award, for significantly improving the precision with which radiation beams can be directed at a tumour.
